After the sixth cycle of chemotherapy, the patient developed grade IV neutropenia with a neutrophil count of 0.5 × 109/L, WBC 1.2 × 109/L, which was treated with the application of Granulocyte colony stimulating factor (G-CSF). This evidence concerns the gene CSF3 and neutropenia.